8-K: Assure Holdings Urges Stockholders to Vote on Share Increase Ahead of Special Meeting

Assure Holdings is reminding its stockholders to vote in favor of a proposal to increase the number of authorized shares, which is critical for the company's future plans.

Summary

• Assure Holdings Corp. has issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized shares from 9,000,000 to 250,000,000.
• The company needs more than 50% of outstanding shares to vote in favor of the proposal for it to pass.
• As of the release, over 95% of the votes received are in favor of the increase, but more votes are needed to reach the required threshold.
• The special meeting of stockholders is scheduled for May 14, 2024, at 2:00 p.m. Pacific Time.
• Failure to vote or abstaining will have the same effect as voting against the proposal.
• The company is also involved in a proposed transaction with Danam Health Inc., and has filed relevant materials with the SEC.

Sentiment

Score: 6

Explanation: The document is neutral in tone, focusing on the need for shareholder action. While the majority of votes are in favor, the risk of not reaching the required threshold and the potential for delays temper the overall sentiment.

Positives

• The vast majority of votes received so far are in favor of the proposed share increase, indicating strong stockholder support.
• The company is actively communicating with stockholders to ensure they understand the importance of voting.
• The company has provided clear instructions on how to vote and who to contact for assistance.

Negatives

• The company needs more votes to reach the required threshold for the share increase proposal to pass.
• Failure to secure the required votes could delay the company's plans.
• The company is relying on smaller stockholders to participate in the vote to reach the required threshold.

Risks

• The proposed share increase may not be approved if the required number of votes is not obtained.
• The proposed merger with Danam Health Inc. is subject to various risks and uncertainties, including regulatory approvals and stockholder approval.
• The company's future operations and financial results are subject to risks and uncertainties, including the ability to obtain sufficient capital.

Future Outlook

The company is focused on obtaining stockholder approval for the share increase and completing the proposed merger with Danam Health Inc. The future success of the company depends on these actions and the ability to manage operating expenses and secure additional capital.

Management Comments

• John Farlinger, Chief Executive Officer and Chairman of Assure, stated that the overwhelming majority of stockholders who have submitted their votes have voted in favor of the proposal.
• Mr. Farlinger emphasized that more votes are needed to meet the required threshold for the proposal to pass.
• Mr. Farlinger encouraged all stockholders to exercise their right to vote and help make the critical increase in capital a reality.

Industry Context

The company operates in the intraoperative neuromonitoring (IONM) and remote neurology services sector, which is a growing field due to the increasing complexity of surgical procedures. The proposed merger with Danam Health Inc. could potentially expand the company's market reach and service offerings.

Comparison to Industry Standards

• It is common for companies in the healthcare sector to seek shareholder approval for increasing authorized shares to facilitate growth and acquisitions.
• The need for a majority vote of outstanding shares is a standard requirement for significant corporate actions.
• The company's reliance on smaller shareholders to participate in the vote is not unusual, as many companies have a diverse shareholder base.

Stakeholder Impact

• Shareholders are directly impacted by the proposed share increase and the merger with Danam Health Inc.
• The company's employees may be impacted by the outcome of the merger and the company's future financial stability.
• Customers may be impacted by any changes in the company's service offerings or operations.

Next Steps

• Stockholders are urged to vote on the proposed share increase before the special meeting on May 14, 2024.
• The company will continue to communicate with stockholders to ensure they are aware of the voting process.
• The company will proceed with the proposed merger with Danam Health Inc. if the share increase is approved.

Key Dates

Keywords

authorized shares, stockholder vote, special meeting, proxy statement, merger, Danam Health, capital increase, IONM, neuromonitoring